close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Recursion Pharmaceuticals, Inc. - Class A Common Stock (NQ:RXRX)

5.520 -0.130 (-2.30%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 43,229,273
Open 5.700
Bid (Size) 5.530 (1)
Ask (Size) 5.540 (14)
Prev. Close 5.650
Today's Range 5.410 - 5.736
52wk Range 3.790 - 12.36
Shares Outstanding 168,425,907
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
The AI Imperative: Why Rapid Upskilling is Non-Negotiable for Pharma’s Future
The pharmaceutical sector stands at the precipice of a profound transformation, driven by the relentless march of artificial intelligence (AI) and other advanced technologies. As highlighted by... 
Via TokenRing AI
Topics Artificial Intelligence Economy
AI Revolutionizes Pharma R&D: A New Era of Accelerated Drug Discovery and Personalized Medicine
Artificial intelligence (AI) is ushering in a transformative era for pharmaceutical research and development (R&D), fundamentally reshaping how new medicines are discovered, developed, and brought to... 
Via TokenRing AI
Topics Artificial Intelligence Intellectual Property

Performance

YTD
-23.4%
-23.4%
1 Month
+13.1%
+13.1%
3 Month
-7.2%
-7.2%
6 Month
+0.4%
+0.4%
1 Year
-17.4%
-17.4%

More News

Read More
Recursion Pharmaceuticals (RXRX) CEO Sells 100,000 Shares
Via The Motley Fool
Could Recursion Pharmaceuticals Be the Next Big Artificial Intelligence (AI) Stock?
Via The Motley Fool
Topics Artificial Intelligence Economy
AI Revolutionizes Drug Discovery and Personalized Medicine: A New Era of Healthcare
Via TokenRing AI
Topics Animal Testing Artificial Intelligence
Looking For The Next Beyond Meat? Here Are The Top 10 Most Shorted Stocks
Via Benzinga
Recursion to Report Third Quarter 2025 Business Updates and Financial Results on November 5th
From Recursion Pharmaceuticals
Via GlobeNewswire
Short Squeeze Frenzy Fuels October's Market Rebound: A Closer Look at Bearish Bets and Bullish Surges
Via MarketMinute
Topics Economy Stocks World Trade
Up 25% in 1 Month, Is This Stock a Buy?
Via The Motley Fool
Topics Animal Testing Artificial Intelligence
WW International, Replimune Group, Datavault AI, GRAIL And Other Big Stocks Moving Higher On Monday
Via Benzinga
Topics Artificial Intelligence
3 Growth Stocks to Invest $1,000 in Right Now
Via The Motley Fool
Most active stocks in Thursday's session
Via Chartmill
Is Recursion Pharmaceuticals a Millionaire Maker?
Via The Motley Fool
Topics Artificial Intelligence Initial Public Offering
Morgan Stanley, T1 Energy, Bunge Global, Bank of America And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
AI Agents Usher in a New Era of Pharmaceutical Discovery: Accelerating Cures to Market
Via TokenRing AI
Topics Artificial Intelligence Intellectual Property
Absci's AI Revolution: A New Era for Drug Discovery or a Rocky Road Ahead?
Via MarketMinute
Topics Artificial Intelligence
2 Reasons Absci Could Be the Future of AI Biotech, and 1 Risk
Via MarketBeat
Topics Artificial Intelligence
4 Healthcare Stocks to Buy Now
Via The Motley Fool
Topics Artificial Intelligence
Costco, AMD, Recursion Pharmaceuticals, Cipher Mining And Snowflake: Why These 5 Stocks Are On Investors' Radars Today
Via Benzinga
Topics Stocks
What's Going On With Recursion Pharmaceuticals Stock On Wednesday?
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Dell, Select Medical, Century Aluminum And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Decoding Life's Blueprint: New Tech Maps RNA-Protein Interactions, Unlocking Disease Cures
Via MarketMinute
Topics Artificial Intelligence Derivatives
AI Revolutionizes Professional Services: A New Era for Doctors, Lawyers, and Consultants
Via MarketMinute
Topics Artificial Intelligence
Nvidia Has Invested in These 6 Companies. Should You Follow Suit?
Via The Motley Fool
Topics Artificial Intelligence

Frequently Asked Questions

Is Recursion Pharmaceuticals, Inc. - Class A Common Stock publicly traded?
Yes, Recursion Pharmaceuticals, Inc. - Class A Common Stock is publicly traded.
What exchange does Recursion Pharmaceuticals, Inc. - Class A Common Stock trade on?
Recursion Pharmaceuticals, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Recursion Pharmaceuticals, Inc. - Class A Common Stock?
The ticker symbol for Recursion Pharmaceuticals, Inc. - Class A Common Stock is RXRX on the Nasdaq Stock Market
What is the current price of Recursion Pharmaceuticals, Inc. - Class A Common Stock?
The current price of Recursion Pharmaceuticals, Inc. - Class A Common Stock is 5.520
When was Recursion Pharmaceuticals, Inc. - Class A Common Stock last traded?
The last trade of Recursion Pharmaceuticals, Inc. - Class A Common Stock was at 10/31/25 04:00 PM ET
What is the market capitalization of Recursion Pharmaceuticals, Inc. - Class A Common Stock?
The market capitalization of Recursion Pharmaceuticals, Inc. - Class A Common Stock is 929.71M
How many shares of Recursion Pharmaceuticals, Inc. - Class A Common Stock are outstanding?
Recursion Pharmaceuticals, Inc. - Class A Common Stock has 930M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today